Literature DB >> 8251751

Rapid purification of cationic granule proteases: application to human granzymes.

W L Hanna1, X Zhang, J Turbov, U Winkler, D Hudig, C J Froelich.   

Abstract

This report describes a simple scheme for the simultaneous purification of cationic human granzymes A, B, and 3 from human interleukin 2 (IL-2)-activated lymphocytes. The process, which requires approximately 8 h, includes: (1) cell cavitation, (2) two centrifugation steps, (3) four granule solubilization steps, and (4) cation-exchange chromatography. Granule solubilization consists of three extractions with a hypotonic buffer (25 mM NaCl) that contained Triton X-100 followed by a final extraction in hypertonic detergent-free buffer (390 mM NaCl). We recovered approximately 35% of the trypsin-like (tryptase) activities mediated by granzymes A and 3, respectively, and approximately 25% of the asp-ase activity of granzyme B. The granzymes were identified after elution from the Mono S column by Western blot with a polyclonal antibody that reacts with a conserved amino acid sequence (9-16) of lymphoid/myeloid serine proteases. By amino-terminal sequencing, eluted granzyme A and B were indeed homogeneous. Granzyme 3, although highly enriched, appears to be contaminated with an uncharacterized granzyme. Although we have developed this scheme to rapidly isolate the granzymes, the procedure should assist the purification of secretory granule-associated cationic proteins that reside in neutrophils and mast cells as well as other cells that possess secretory function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251751     DOI: 10.1006/prep.1993.1052

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

1.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

2.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

3.  Perforin oligomers form arcs in cellular membranes: a locus for intracellular delivery of granzymes.

Authors:  S S Metkar; M Marchioretto; V Antonini; L Lunelli; B Wang; R J C Gilbert; G Anderluh; R Roth; M Pooga; J Pardo; J E Heuser; M D Serra; C J Froelich
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

4.  Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Christopher J Froelich; Simon C Watkins; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

5.  Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid.

Authors:  M Barry; J A Heibein; M J Pinkoski; S F Lee; R W Moyer; D R Green; R C Bleackley
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore.

Authors:  S T Wasilenko; A F Meyers; K Vander Helm; M Barry
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins.

Authors:  Jenny Odeberg; Helena Browne; Sunil Metkar; Christopher J Froelich; Lars Brandén; David Cosman; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B.

Authors:  L T Quan; M Tewari; K O'Rourke; V Dixit; S J Snipas; G G Poirier; C Ray; D J Pickup; G S Salvesen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

9.  NF-kappaB protects from the lysosomal pathway of cell death.

Authors:  Ni Liu; Srikumar M Raja; Francesca Zazzeroni; Sunil S Metkar; Ramila Shah; Manling Zhang; Yue Wang; Dieter Brömme; William A Russin; Justine C Lee; Marcus E Peter; Christopher J Froelich; Guido Franzoso; Philip G Ashton-Rickardt
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

Authors:  P C Wever; H J Van Der Vliet; L H Spaeny; A M Wolbink; F N Van Diepen; C J Froelich; C E Hack; I J ten Berge
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.